JPH0672838A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH0672838A JPH0672838A JP3029471A JP2947191A JPH0672838A JP H0672838 A JPH0672838 A JP H0672838A JP 3029471 A JP3029471 A JP 3029471A JP 2947191 A JP2947191 A JP 2947191A JP H0672838 A JPH0672838 A JP H0672838A
- Authority
- JP
- Japan
- Prior art keywords
- water
- extract
- cosmetic
- coconut palm
- action
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 41
- 235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 30
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 27
- 244000060011 Cocos nucifera Species 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 48
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 9
- 238000010438 heat treatment Methods 0.000 abstract description 7
- 230000002087 whitening effect Effects 0.000 abstract description 7
- 239000006071 cream Substances 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 239000003021 water soluble solvent Substances 0.000 abstract description 4
- 239000000839 emulsion Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 239000002453 shampoo Substances 0.000 abstract description 2
- 230000003796 beauty Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 241000737241 Cocos Species 0.000 description 26
- 230000000694 effects Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 15
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 244000280244 Luffa acutangula Species 0.000 description 13
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000001704 evaporation Methods 0.000 description 9
- 230000008020 evaporation Effects 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 102000003425 Tyrosinase Human genes 0.000 description 8
- 108060008724 Tyrosinase Proteins 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229960001340 histamine Drugs 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 241001116389 Aloe Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- -1 Polyoxyethylene Polymers 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 235000011399 aloe vera Nutrition 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- DENMGZODXQRYAR-UHFFFAOYSA-N 2-(dimethylamino)ethanethiol Chemical class CN(C)CCS DENMGZODXQRYAR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 240000008107 Arenga engleri Species 0.000 description 1
- 235000004019 Arenga engleri Nutrition 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical class NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- AYOOGWWGECJQPI-NSHDSACASA-N n-[(1s)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(3-propan-2-yloxy-1h-pyrazol-5-yl)imidazo[4,5-b]pyridin-5-amine Chemical compound N1C(OC(C)C)=CC(N2C3=NC(N[C@@H](C)C=4N=CC(F)=CN=4)=CC=C3N=C2)=N1 AYOOGWWGECJQPI-NSHDSACASA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、新規な化粧料に関す
る。さらに詳しくは、ココツヤシの果実の水溶性抽出物
を有効成分として含有する美白作用、抗炎症作用および
保水力を併せ持つ化粧料に関する。FIELD OF THE INVENTION The present invention relates to a novel cosmetic. More specifically, the present invention relates to a cosmetic having a whitening effect, an anti-inflammatory effect, and a water retention ability, which contains a water-soluble extract of coconut palm fruit as an active ingredient.
【0002】[0002]
【従来の技術】皮膚のしみ、そばかすなどの発生機構に
ついては不明な点もあるが、一般には、ホルモンの異常
や日光からの紫外線の刺激が原因となってメラニン色素
が形成され、これが皮膚内に異常沈着するものと考えら
れている。この様な、しみやそばかすの治療には、皮膚
内に存在するチロジナ−ゼ活性を阻害してメラニン生成
を抑制する物質、例えば、ビタミンCを大量に投与する
方法、グルタチオンを軟膏、クリ−ム、ロ−ションなど
の形態にして局所に塗布する方法などがとられている。
また、欧米ではハイドロキノン製剤が医薬品として用い
られている。BACKGROUND OF THE INVENTION Although there are some unclear points regarding the mechanism of skin spots, freckles, etc., melanin pigments are generally formed due to hormonal abnormalities and ultraviolet rays from the sun, and this is due to the fact that the It is thought that it will be abnormally deposited. For the treatment of such stains and freckles, a substance that inhibits the thyrodinase activity present in the skin and suppresses melanin production, for example, a method in which a large amount of vitamin C is administered, glutathione is an ointment, and cream is used. , A lotion or the like and locally applying it.
In Europe and America, hydroquinone preparations are used as medicines.
【0003】一方、さまざまな皮膚刺激、例えば、紫外
線の作用により皮膚は炎症を起こすが、これらの炎症を
抑制するものが、抗炎症剤であり、化粧料用成分として
は、アロエ、ヘチマ等の植物抽出物、グリチルリチン、
亜鉛華等が用いられている。On the other hand, the skin is irritated by various skin stimuli, for example, the action of ultraviolet rays, and those which suppress these inflammations are anti-inflammatory agents, and as ingredients for cosmetics, aloe, loofah, etc. Plant extract, glycyrrhizin,
Zinc white or the like is used.
【0004】また、皮膚の角質層より水分が減少すると
肌荒れなどの原因となる。角質層に適当な水分含量を与
えるため、保湿剤として、グリセリン、1,3−ブチレ
ングリコ−ル、プロピレングリコール、ヒアルロン酸等
が用いられている。Further, if the water content in the stratum corneum of the skin decreases, it may cause rough skin. Glycerin, 1,3-butylene glycol, propylene glycol, hyaluronic acid and the like are used as moisturizing agents in order to give an appropriate water content to the stratum corneum.
【0005】[0005]
【発明が解決しようとする課題】ビタミンC類は、熱、
光に対し経時的安定性が悪く、特に、水分を含む系で変
色、変臭の原因となる。一方、ハイドロキノン系は皮膚
刺激、アレルギー性等の安全性に問題があるため、使用
が制限されている。また、空気酸化されやすいため安定
性の面においても問題がある。グルタチオン、システイ
ン等のチオ−ル系化合物は異臭が強い上、酸化されやす
く効果も緩慢である。また、2−メルカプトエチルアミ
ン塩、N−(2−メルカプトエチル)ジメチルアミン塩
等は、黒色モルモットの皮膚を脱色することが知られて
いるが、脱色後に白班が生じやすいので、一般には使用
されていない。[Problems to be Solved by the Invention] Vitamin C contains heat,
It has poor stability over time with respect to light, and causes discoloration and odor particularly in systems containing water. On the other hand, the use of hydroquinone type is limited because of its safety problems such as skin irritation and allergenicity. Further, there is a problem in terms of stability because it is easily oxidized by air. Thiol-based compounds such as glutathione and cysteine have a strong offensive odor and are easily oxidized and their effects are slow. In addition, 2-mercaptoethylamine salt, N- (2-mercaptoethyl) dimethylamine salt and the like are known to decolorize the skin of black guinea pigs, but since white spots easily occur after decolorization, they are generally used. Absent.
【0006】一方、美白作用、抗炎症作用および保湿作
用を有する成分は前記のごとく様々なものがあるが、そ
れらの効果を合わせもつ化粧料を製造するためには、そ
れらの複数の成分をそれぞれ添加するしかなく、製品の
安定性等留意しなければならない点が多い。On the other hand, there are various components having a whitening action, an anti-inflammatory action and a moisturizing action, as described above, but in order to produce a cosmetic having these effects, a plurality of these components are respectively added. There are many things to be noted such as the stability of the product, which must be added.
【0007】本発明者らは、かかる状況を鑑み、鋭意研
究を重ねた結果、ココツヤシの果実の水溶性抽出物を有
効成分として含有する化粧料が、良好な美白作用、抗炎
症作用および保水力を有することを見いだし、本発明を
完成するに至った。[0007] In view of the above situation, the inventors of the present invention have conducted extensive studies and found that a cosmetic containing a water-soluble extract of coconut palm fruit as an active ingredient has good whitening action, anti-inflammatory action and water retention ability. The present invention has been completed and the present invention has been completed.
【0008】[0008]
【課題を解決するための手段】本発明は、ココツヤシの
果実の水溶性抽出物を有効成分として含有する化粧料で
ある。The present invention is a cosmetic containing a water-soluble extract of coconut palm fruit as an active ingredient.
【0009】本発明で使用するココツヤシとは、ヤシ科
(Palmae)クロッグ(Arenga engleri)属で常緑低木で
高さは普通2mたらずである。幹は黒褐色多数束生す
る。葉は長さ2〜3m、表面は濃緑色で光沢があり、裏
面は白っぽい。小葉は長さ70cm、幅4cmくらい。
葉柄の基部には黒褐色の葉鞘網が密生する。雌雄同株で
雄花は雌花より1月早く咲く。花被は黄色、長さ約2c
m、果実は液果で赤く熟し球形、径2cm弱。種子は黒
色で、長さ約1cm。(平凡社 寺崎植物図鑑,寺崎留
吉著)The coconut palm used in the present invention is a genus of Palmae clogs (Arenga engleri), which is an evergreen shrub and is usually less than 2 m in height. Many trunks are dark brown. The leaves are 2-3 m long, the surface is dark green and shiny, and the back is whitish. The leaflets are 70 cm long and 4 cm wide.
A blackish brown leaf sheath network is densely formed at the base of the petiole. Male and female flowers of the same strain bloom one month earlier than female flowers. The flower cover is yellow and the length is about 2c.
m, the fruits are berries, ripe red, spherical, and slightly less than 2 cm in diameter. The seeds are black and about 1 cm long. (Heibonsha Terasaki Botanical Encyclopedia, Ryukichi Terasaki)
【0010】本発明で使用する水溶性溶媒とは水もしく
は水に可溶な溶媒で、例えば、水、アルコ−ル類(メタ
ノ−ル、エタノ−ル、1,3−ブチレングリコール、プ
ロピレングリコール等)、アセトンなどのが挙げられ
る。また、本発明の植物の果実の抽出は、これらの水溶
性溶媒の1種または2種以上の混合溶媒を用いて抽出し
たものであっても良い。また、加熱抽出したものであっ
ても良いし、常温抽出したものであっても良い。必要に
応じて、濃縮あるいは希釈して化粧品原料として用いる
ことが出来る。The water-soluble solvent used in the present invention is water or a water-soluble solvent such as water, alcohols (methanol, ethanol, 1,3-butylene glycol, propylene glycol, etc.). ), Acetone and the like. Moreover, the extraction of the fruit of the plant of the present invention may be carried out by using one or a mixture of two or more of these water-soluble solvents. Further, it may be one extracted by heating or one extracted at room temperature. If necessary, it can be concentrated or diluted and used as a cosmetic raw material.
【0011】本発明の化粧料には、ココツヤシの果実の
水溶性抽出物の効果を損なわない範囲内で、油脂類、ロ
ウ類、炭化水素類、脂肪酸類、アルコ−ル類、エステル
類、金属石鹸、界面活性剤などを原料として配合するこ
とができる。The cosmetics of the present invention contain oils and fats, waxes, hydrocarbons, fatty acids, alcohols, esters and metals as long as the effect of the water-soluble extract of coconut palm is not impaired. Soaps, surfactants and the like can be blended as raw materials.
【0012】これらの基材を原料として製造される化粧
料としては、例えば、化粧水、クリ−ム、乳液、シャン
プ−、ファンデ−ション、リップクリ−ム、口紅などが
挙げられる。Examples of cosmetics produced from these base materials as raw materials include lotion, cream, emulsion, shampoo, foundation, lip cream, lipstick and the like.
【0013】本発明の化粧料に用いるココツヤシの果実
の水溶性抽出物の使用量は、溶媒を留去して得られた固
形分として、化粧料全体に対して0.01から10重量
%、好ましくは、0.1から5.0重量%配合するのが
適当である。0.01重量%未満では十分な効果が望め
ず、10重量%を越えて配合しても効果の増強がなく不
経済である。The amount of the water-soluble extract of coconut palm fruit used in the cosmetic of the present invention is 0.01 to 10% by weight, based on the total amount of the cosmetic, as solid content obtained by distilling off the solvent. It is preferable to add 0.1 to 5.0% by weight. If it is less than 0.01% by weight, no sufficient effect can be expected, and if it exceeds 10% by weight, the effect is not enhanced and it is uneconomical.
【0014】また、添加の方法については、予め加えて
おいても、製造途中で添加しても良く、作業性を考え
て、適宜選択すれば良い。Regarding the method of addition, it may be added in advance or may be added during the production, and may be appropriately selected in consideration of workability.
【0015】[0015]
【実施例】以下に実施例を挙げて本発明を更に具体的に
説明するが、本発明は何らこれらに限定されるものでは
ない。なお、実施例に示す部とは重量部を、%とは重量
%を示す。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto. The parts shown in the examples are parts by weight, and% is% by weight.
【0016】実施例−1 ココツヤシの果実500gを細断し、水500mlで2時
間ずつ2回加熱抽出し、さらに真空凍結乾燥により濃縮
することにより抽出物10g(99%以上の固形物を含
む)を得た。Example 1 Coconut palm fruit (500 g) was shredded, heat-extracted with 500 ml of water twice for 2 hours each time, and further concentrated by vacuum freeze-drying to obtain 10 g of extract (containing solids of 99% or more). Got
【0017】実施例−2 乾燥したココツヤシの果実60gを粉砕し、水−エタノ
−ル混液(1:1)600mlで5時間加熱抽出して、さ
らに濃縮することにより抽出物5g(50%の固形物を
含む)を得た。Example 2 60 g of dried coconut palm fruit was crushed, heat-extracted with 600 ml of a water-ethanol mixed solution (1: 1) for 5 hours, and further concentrated to obtain 5 g of the extract (solid content of 50%). (Including things).
【0018】実施例−3 乾燥したココツヤシの果実60gを粉砕し、エタノ−ル
300mlを加え、常温で1カ月放置する。さらに濃縮す
ることにより抽出物5g(99%以上の固形物を含む)
を得た。Example 3 60 g of dried coconut palm fruit was crushed, 300 ml of ethanol was added, and the mixture was allowed to stand at room temperature for 1 month. 5g of extract by further concentration (including 99% or more solids)
Got
【0019】実施例−4 乾燥したココツヤシの果実60gを粉砕し、プロパノ−
ル600mlで2時間ずつ2回加熱抽出し、さらに濃縮
することにより抽出物3g(70%の固形物を含む)を
得た。Example 4 60 g of dried coconut palm fruit was crushed and propanoed.
The mixture was heated and extracted twice with 600 ml each for 2 hours, and further concentrated to obtain 3 g of an extract (containing 70% of solid matter).
【0020】 実施例−5 化粧水 (1)ココツヤシの果実の熱水抽出物 (固形物として99%) 5.0 部 (2)グリセリン 2.0 (3)エチルアルコ−ル 7.0 (4)パラオキシ安息香酸メチル 0.05 (5)ポリオキオシエチレン (20)ラウリルエ−テル 0.5 (6)クエン酸 0.01 (7)クエン酸ナトリウム 0.1 (8)香料 0.1 (9)精製水にて全量を100とする 成分(2)〜(4)を混合して溶解する。別に成分
(1)、(5)〜(8)を混合して溶解する。ついで両
者を混合し、テトロン製布(300メッシュ)により濾
過し、製品とする。Example-5 Lotion (1) Hot water extract of coconut palm fruit (99% as a solid) 5.0 parts (2) Glycerin 2.0 (3) Ethyl alcohol 7.0 (4) Methyl paraoxybenzoate 0.05 (5) Polyoxyethylene (20) Lauryl ether 0.5 (6) Citric acid 0.01 (7) Sodium citrate 0.1 (8) Perfume 0.1 (9) The components (2) to (4) having a total amount of 100 are mixed with purified water and dissolved. Separately, the components (1) and (5) to (8) are mixed and dissolved. Then, both are mixed and filtered through a Tetoron cloth (300 mesh) to obtain a product.
【0021】 実施例−6 クリーム (1)ココツヤシの果実の熱水抽出物 (固形物として99%) 2.0 部 (2)スクワラン 5.5 (3)オリーブ油 3.0 (4)ステアリン酸 2.0 (5)ミツロウ 2.0 (6)ミリスチン酸オクチルドデシル 3.5 (7)ポリオキシエチレン(20) セチルエーテル 3.0 (8)ベヘニルアルコール 1.5 (9)グリセリンモノステアレート 2.5 (10)1,3−ブチレングリコール 8.5 (11)パラオキシ安息香酸メチル 0.2 (12)パラオキシ安息香酸エチル 0.05 (13)香料 0.1 (14)精製水にて全量を100とする 成分(2)〜(9)を加熱溶解して混合し、70℃に保
ち油相とする。成分(1)、(10)〜(12)を成分
14に加熱溶解して混合し、75℃に保ち水相とする。
油相に水相を加えて乳化し、成分(13)を加えてかき
混ぜながら、30℃まで冷却して製品とする。Example-6 Cream (1) Hot water extract of coconut palm fruit (99% as solid) 2.0 parts (2) Squalane 5.5 (3) Olive oil 3.0 (4) Stearic acid 2 0.0 (5) Beeswax 2.0 (6) Octyldodecyl myristate 3.5 (7) Polyoxyethylene (20) Cetyl ether 3.0 (8) Behenyl alcohol 1.5 (9) Glycerin monostearate 2.5 (10) 1,3-Butylene glycol 8.5 (11) Methyl paraoxybenzoate 0.2 (12) Ethyl paraoxybenzoate 0.05 (13) Perfume 0.1 (14) Total amount to 100 with purified water. The components (2) to (9) are dissolved by heating and mixed, and the mixture is kept at 70 ° C. to obtain an oil phase. Ingredients (1) and (10) to (12) are heated and dissolved in ingredient 14 and mixed, and the mixture is kept at 75 ° C to form an aqueous phase.
The aqueous phase is added to the oil phase to emulsify, component (13) is added, and the mixture is stirred and cooled to 30 ° C. to obtain a product.
【0022】 実施例−7 乳液 (1)ココツヤシの果実のエタノール抽出物 (固形分として99%) 1.0 (2)スクワラン 5.0 (3)オリーブ油 5.0 (4)ホホバ油 5.0 (5)セチルアルコール 1.5 (6)グリセリンモノステアレート 2.0 (7)ポリオキシエチレン(20) セチルエーテル 3.0 (8)ポリオキシエチレン(20) ソルビタンモノオレエート 2.0 (9)ジプロピレングリコール 1.0 (10)グリセリン 2.0 (11)香料 0.1 (12)パラオキシ安息香酸メチル 0.2 (13)精製水にて全量を100とする 成分(2)〜(8)を加熱溶解して混合し、70℃に保
ち油相とする。成分(1)、(9)、(10)、(1
2)を成分(13)に加熱溶解して混合し、75℃に保
ち水相とする。油相に水相を加えて乳化分散し、成分
(11)を加えてかき混ぜながら、30℃まで冷却し製
品とする。Example-7 Emulsion (1) Ethanol extract of coconut palm fruit (99% as solid content) 1.0 (2) Squalane 5.0 (3) Olive oil 5.0 (4) Jojoba oil 5.0 (5) Cetyl alcohol 1.5 (6) Glycerin monostearate 2.0 (7) Polyoxyethylene (20) cetyl ether 3.0 (8) Polyoxyethylene (20) sorbitan monooleate 2.0 (9 ) Dipropylene glycol 1.0 (10) Glycerin 2.0 (11) Perfume 0.1 (12) Methyl paraoxybenzoate 0.2 (13) Total amount to 100 with purified water Components (2) to (8) ) Is melted by heating and mixed, and the mixture is kept at 70 ° C. to obtain an oil phase. Components (1), (9), (10), (1
2) is dissolved in the component (13) by heating and mixed, and the mixture is kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify and disperse, and the component (11) is added and stirred to cool to 30 ° C. to obtain a product.
【0023】 実施例−8 パック (1)ココツヤシの果実のプロピレングリコール 抽出物(固形物として20%) 3.0 部 (2)ポリビニルアルコール 11.5 (3)1,3−ブチレングリコール 2.5 (4)ポリオキシエチレン(40) 硬化ヒマシ油 1.0 (5)エチルアルコール 7.0 (6)パラオキシ安息香酸メチル 0.2 (7)香料 0.05 (8)精製水にて全量を100とする 成分(1)から(8)を75℃にて加温溶解し、30℃
まで冷却し製品とする。Example-8 Pack (1) Propylene Glycol Extract of Coconut Palm Fruit (20% as Solid) 3.0 parts (2) Polyvinyl Alcohol 11.5 (3) 1,3-Butylene Glycol 2.5 (4) Polyoxyethylene (40) Hydrogenated castor oil 1.0 (5) Ethyl alcohol 7.0 (6) Methyl paraoxybenzoate 0.2 (7) Perfume 0.05 (8) The total amount is 100 with purified water. The components (1) to (8) are dissolved by heating at 75 ℃, 30 ℃
Cool down to product.
【0024】[0024]
【発明の効果】本発明のココツヤシの果実の水溶性抽出
物を有効成分として含有する化粧料は、安定性の高い美
白作用、抗炎症作用および保水力をあわせ持ち、かつ安
全性においても好ましいものである。以下、実験例を挙
げて本発明の効果を説明する。EFFECTS OF THE INVENTION A cosmetic containing the water-soluble extract of coconut palm of the present invention as an active ingredient has a highly stable whitening action, an anti-inflammatory action and a water retention ability, and is also preferable in terms of safety. Is. Hereinafter, the effects of the present invention will be described with reference to experimental examples.
【0025】[実験例]有効性試験例1 美白作用 チロジナーゼ活性阻害作用を調べるため、試料の0.1
5%水溶液について37℃、2週間の保温処理をする前
後のチロジナーゼ活性阻害力を測定した。比較例とし
て、従来より化粧料として用いられているアスコルビン
酸、ヘチマ水およびヘチマ果実の熱水抽出物を同様に試
験した。なお、試料は実施例1で得られた抽出物を用い
た。またヘチマの熱水抽出物(比較例)の調製方法とし
ては、乾燥品10gを熱水抽出(95℃、3時間、30
0ml)後、濾液を真空凍結乾燥した。[Experimental Example] Efficacy Test Example 1 Whitening Action To examine the inhibitory action on tyrosinase activity, 0.1
The tyrosinase activity inhibitory ability of the 5% aqueous solution was measured before and after the incubation at 37 ° C. for 2 weeks. As a comparative example, ascorbic acid, loofah water, and hot water extract of loofah fruits, which have been conventionally used as cosmetics, were similarly tested. The sample used was the extract obtained in Example 1. The hot water extract of loofah (comparative example) was prepared by extracting 10 g of the dried product with hot water (95 ° C, 3 hours, 30 hours).
(0 ml), the filtrate was lyophilized in vacuo.
【0026】チロジナーゼ活性阻害作用の測定;試験管
にL-チロシン溶液(0.3mg/ml)を1ml、マッ
クスベイン氏の緩衝液(pH6.8)を1ml、および
前記試料の0.15%水溶液0.9mlを加えて、37
℃の恒温水槽中で10分間インキュベートした。これに
チロジナーゼ水溶液(1mg/ml)を0.1ml加え
てよく攪拌し、37℃、12分間インキュベート後、分
光光度計にセットして475nmにおける吸光度を測定
した。一方、ブランクとして前記試料の代わりに蒸留水
を用いて同様の吸光度測定を行い、各試料のチロジナー
ゼ活性阻害率を次式より算出した。なお、式中のAは各
試料を添加した場合の吸光度を、Bはブランクの吸光度
を意味する。 阻害率(%)=(1−A/B)×100Measurement of tyrosinase activity inhibitory action: 1 ml of L-tyrosine solution (0.3 mg / ml), 1 ml of Max Bain's buffer (pH 6.8), and 0.15% aqueous solution of the sample in a test tube Add 0.9 ml to 37
Incubated for 10 minutes in a constant temperature water bath at ℃. 0.1 ml of an aqueous solution of tyrosinase (1 mg / ml) was added thereto, well stirred, incubated at 37 ° C. for 12 minutes, set in a spectrophotometer, and the absorbance at 475 nm was measured. On the other hand, the same absorbance measurement was performed using distilled water instead of the above sample as a blank, and the tyrosinase activity inhibition rate of each sample was calculated from the following formula. In the formula, A means the absorbance when each sample was added, and B means the absorbance of the blank. Inhibition rate (%) = (1−A / B) × 100
【0027】これらの試験結果を表1に示す。表1より
明らかなように実施例−1で得たココツヤシの果実の水
溶性抽出物は、ヘチマ水およびヘチマの熱水抽出物より
も顕著なチロジナーゼ活性阻害力を有しており、更にこ
の組成物は熱安定性が良く、37℃、2週間放置後で
は、ビタミンCよりも強力なチロジナーゼ活性阻害力を
有していることが認められる。また、これらの安定性試
験により、ココツヤシの果実の水溶性抽出は変臭、変色
が見られなかった。さらに実施例2〜4で得られたココ
ツヤシの果実の水溶性抽出物も同様に試験したところ、
同程度に良好なチロジナーゼ活性阻害力を示すことが判
った。 (以下余白)The results of these tests are shown in Table 1. As is clear from Table 1, the water-soluble extract of coconut palm fruit obtained in Example-1 has a more remarkable thyrodinase activity inhibitory activity than loofah water and hot water extract of loofah. It is recognized that the product has a good thermostability and has a stronger tyrosinase activity inhibitory effect than that of vitamin C after standing for 2 weeks at 37 ° C. In addition, in these stability tests, no odor or discoloration was observed in the water-soluble extract of coconut palm fruit. Furthermore, when the water-soluble extracts of coconut palm fruits obtained in Examples 2 to 4 were tested in the same manner,
It was found that they showed equally good tyrosinase activity inhibitory activity. (Below margin)
【0028】[0028]
【表1】 チロジナーゼ活性阻害作用 ────────────────────────── 試料 濃度 活性阻害率(%) (%) ─────────── 加温前 加温後 ────────────────────────── 実施例−1 0.15 60 60 ビタミンC 0.15 95 26 ヘチマ水 0.15 95 9 ヘチマの 0.15 32 32 熱水抽出物 ────────────────────────── [Table 1] Tyrosinase activity inhibition ────────────────────────── Sample concentration Activity inhibition rate (%) (%) ───── ────── Before heating ────────────────────────── Example-1 0.15 60 60 Vitamin C 0 15 95 26 Loofah water 0.15 95 9 Loofah 0.15 32 32 Hot water extract ───────────────────────────
【0029】有効性試験例2 抗炎症作用 抗炎症作用を調べるため、試料を0.01%、0.1
%、1.0%含有する各水溶液について、ヒスタミン遊
離抑制試験を実施した。比較例として従来より化粧料に
用いられているヘチマ水およびキタチアロエの熱水抽出
物を同様に試験した。ココツヤシの水溶性抽出物、ヘチ
マ水およびヘチマの熱水抽出物は実験例1で使用したも
のと同じである。 Efficacy test example 2 Anti-inflammatory effect In order to investigate the anti-inflammatory effect, a sample of 0.01%, 0.1
% And 1.0% of each aqueous solution, a histamine release inhibition test was carried out. As a comparative example, hot water extracts of loofah water and Kitia aloe, which have been conventionally used in cosmetics, were similarly tested. The water-soluble extract of coconut palm, loofah water and hot water extract of loofah are the same as those used in Experimental Example 1.
【0030】ヒスタミン遊離抑制試験;平井らの報告
(生薬学雑誌、37、374、1983.)に従って、雄性Spraqu
e-Dawley系ラット(200から450g)の腹腔内から
採取した肥満細胞に対するヒスタミン遊離抑制作用を測
定した。すなわち、4ppmのコンパウンド48/80
によるヒスタミン遊離を抑制する作用を遊離抑制率
(%)として求めた。Histamine release inhibition test; Male Spraqu according to the report of Hirai et al. (Biopharmaceutical Journal, 37 , 374, 1983.).
The histamine release inhibitory effect on mast cells collected from the abdominal cavity of e-Dawley rats (200 to 450 g) was measured. Ie 4 ppm compound 48/80
The inhibitory effect on histamine release by A. was determined as the release inhibition rate (%).
【0031】結果を表2に示す。これらの結果から、実
施例−1で得たココツヤシの果実の熱水抽出物はヘチマ
水およびキタチアロエの熱水抽出物と比較して、顕著な
ヒスタミン遊離抑制作用が認められ、抗炎症作用も優れ
ていることを見出した。また実施例2〜4で得られたコ
コツヤシの果実の水溶性抽質物も同様に試験したとこ
ろ、良好な抗炎症作用を示すことが判った。The results are shown in Table 2. From these results, the hot water extract of the fruit of the coconut palm obtained in Example-1 has a remarkable histamine release inhibitory action as compared with the hot water extract of loofah water and Kitia aloe, and also has an excellent anti-inflammatory action. I found that. Further, when the water-soluble extract of the fruit of the coconut palm obtained in Examples 2 to 4 was tested in the same manner, it was found that it showed a good anti-inflammatory action.
【0032】[0032]
【表2】 ヒスタミン遊離抑制作用 ────────────────────────── 試料 濃度 ヒスタミン (%) 遊離抑制率(%) ────────────────────────── 実施例−1 1.0 100 0.1 99 0.01 65 ヘチマ水 1.0 65 0.1 23 0.01 13 キタチアロエ 1.0 80 熱水抽出物 0.1 61 0.01 35 ────────────────────────── [Table 2] Histamine release inhibitory effect ────────────────────────── Sample concentration Histamine (%) Release inhibitory rate (%) ──── ────────────────────── Example-1 1.0 100 0.1 99 0.01 0.01 65 loofah water 1.0 65 0.1 23 23. 01 13 Kitta aloe 1.0 80 Hot water extract 0.1 61 0.01 35 35 ───────────────────────────
【0033】有効性試験例3 保湿作用 試料0.5および7.0%水溶液について、水分蒸発阻
止率を測定した。比較として従来から保湿剤として化粧
料に用いられているグリセリンを、ブランクとして蒸留
水を用いて同様に試験した。試料は実施例−1で得られ
た熱水抽出物を用いた。 Efficacy Test Example 3 Moisturizing Effect The moisture evaporation inhibition rate was measured for samples 0.5 and 7.0% aqueous solutions. For comparison, glycerin, which has been conventionally used as a moisturizer in cosmetics, was similarly tested using distilled water as a blank. The hot water extract obtained in Example-1 was used as the sample.
【0034】水分蒸発阻止率の測定方法;2mlの各試料
液を標量瓶に入れ、温度25℃、相対湿度50%で静置
する。4日間静置後、各試料溶液の水分蒸発量を測定
し、水分蒸発率を次式より算出した。なお、式中のAは
各試料の水分蒸発量、Bはブランク(蒸留水)の水分蒸
発量を意味する。 阻止率(%)=(1−A/B)×100Method for measuring water vapor evaporation inhibition rate: 2 ml of each sample solution is placed in a standard bottle and allowed to stand at a temperature of 25 ° C. and a relative humidity of 50%. After standing for 4 days, the water evaporation amount of each sample solution was measured, and the water evaporation rate was calculated from the following equation. In the formula, A means the water evaporation amount of each sample, and B means the water evaporation amount of the blank (distilled water). Rejection rate (%) = (1-A / B) × 100
【0035】これらの試験結果を表3に示す。結果より
明らかなように、本発明の実施例−1で得た熱水抽出物
は、グリセリンと同程度の水分蒸発阻止率が得られ、保
水力に優れていることを見出した。The results of these tests are shown in Table 3. As is clear from the results, the hot water extract obtained in Example-1 of the present invention was found to have a water evaporation inhibition rate similar to that of glycerin, and to be excellent in water retention.
【0036】[0036]
【表3】 水分蒸発阻止率 ─────────────────────────── 試料 試料濃度(%) 水分蒸発阻止率(%) ─────────────────────────── 実施例−1 0.5 5.0 7.0 31.5 グリセリン 0.5 5.0 7.0 32.8 ─────────────────────────── [Table 3] Moisture evaporation inhibition rate ─────────────────────────── Sample Sample concentration (%) Moisture evaporation inhibition rate (%) ── ───────────────────────── Example-1 0.5 5.0 7.0 31.5 Glycerin 0.5 5.0 7. 0 32.8 ────────────────────────────
【0037】有効性試験例4 使用試験 健康な被験者30名を用いて使用試験を実施した。試料
は実施例−5および6の化粧料を用い、ココツヤシの果
実の水溶性抽出物の重量%を各々変化させ用いた。被験
者の前腕内側部の2cm平方のサイトに、UV−Bラン
プ(東芝FL−20SE)を用い、3mw/cm2の強
度の紫外線を1分間照射した。各サイトに先の各試料を
3日間毎日朝夕の2回塗布した後、炎症の抑制効果をア
ンケ−ト調査し評価を行った。1カ月間使用後の色素沈
着の抑制効果および肌のしっとり感についてもアンケ−
ト調査を行って評価を行った。なお、紫外線照射したう
ちの1サイトは何も塗布しないコントロ−ルとした。ア
ンケ−トの判定基準は下記に基ずいてコントロ−ルと比
較して評価を行った。 (判定基準) 有効 ◎ やや有効 ○ ほとんど無効 △ 無効 × (以下余白) Efficacy Test Example 4 Usage Test A usage test was carried out using 30 healthy subjects. As the samples, the cosmetics of Examples 5 and 6 were used, and the weight% of the water-soluble extract of coconut palm fruit was changed. A UV-B lamp (TOSHIBA FL-20SE) was used to irradiate the site of 2 cm square on the inner side of the forearm of the subject with ultraviolet rays having an intensity of 3 mw / cm 2 for 1 minute. Each sample was applied to each site twice daily in the morning and evening for 3 days, and then the effect of suppressing inflammation was surveyed and evaluated. The effect of suppressing pigmentation after one month of use and the moist feeling of the skin are also questioned.
An evaluation was performed by conducting a survey. Incidentally, one of the sites irradiated with ultraviolet rays was a control in which nothing was applied. The evaluation criteria of the questionnaire were based on the following, and evaluated in comparison with the control. (Judgment Criteria) Valid ◎ Slightly Valid ○ Almost Invalid △ Invalid × (Margins below)
【0038】[0038]
【表4−1】 炎症の抑制効果のアンケート結果 (以下余白)[Table 4-1] Questionnaire results on the effect of suppressing inflammation (Below margin)
【0039】 (以下余白)[0039] (Below margin)
【0040】[0040]
【表4−3】 肌のしっとり感のアンケートの結果 [Table 4-3] Results of questionnaire on skin moisturization
【0041】表4の結果により本発明で用いる化粧料は
著効な日焼け後の炎症および色素沈着の抑制効果を示
し、肌のしっとり感においても良好な効果を示すことが
判る。From the results shown in Table 4, it can be seen that the cosmetics used in the present invention exhibit a remarkable effect of suppressing inflammation and pigmentation after sunburn, and also exhibit a good effect on the moist feeling of the skin.
【0042】有効性試験例5 安全性試験 本発明のココツヤシの果実の水溶性抽出物の安全性を明
らかにするため、ヒトに対する一次刺激性試験を閉塞パ
ッチテストにより行った。すなわち、フィンチャンバ−
(EPITEST 社製)を用い、健康人30名に対し、前腕屈
側部に48時間閉塞貼付を行い、パッチテスト用絆創膏
除去後、1時間後、24時間後、48時間後の判定の平
均値を用いて判定した。試料は実施例1で得られた水抽
出物を用い、塗布濃度は10%(W/W)水溶液とし、
対照として蒸留水を使用した。判定結果、ココツヤシの
果実の水抽出物では全く紅班を認めず、一方、対照の蒸
留水では5名にわずかな紅班を認めた。これらの結果か
らココツヤシの水溶性抽出物は一次刺激性が極めて低
く、皮膚に対して安全が高いことが確認された。また、
実施例2〜4で得られたココツヤシの果実の水溶性抽出
物も同様に試験し、皮膚に対して同様に安全性が高いこ
とが認められた。 Efficacy Test Example 5 Safety Test In order to clarify the safety of the water-soluble extract of coconut palm fruit of the present invention, a primary irritation test for humans was conducted by an occlusive patch test. That is, the fin chamber
Using EPITEST, 30 healthy people were occluded on the flexed side of the forearm for 48 hours, and after removal of the patch test plaster, the average value of the judgments made 1 hour, 24 hours, and 48 hours later. It was judged using. As the sample, the water extract obtained in Example 1 was used, and the coating concentration was 10% (W / W) aqueous solution.
Distilled water was used as a control. As a result of the determination, no erythema was observed in the water extract of coconut palm fruit, while a slight erythema was observed in 5 of the distilled water as a control. From these results, it was confirmed that the water-soluble extract of coconut palm has extremely low primary irritation and is highly safe to the skin. Also,
The water-soluble extracts of coconut palm fruits obtained in Examples 2 to 4 were also tested in the same manner, and were found to be similarly highly safe to the skin.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 物部 彰夫 愛知県名古屋市西区鳥見町2丁目130番地 日本メナード化粧品株式会社中央研究所 内 (72)発明者 福永 巌 愛知県名古屋市西区鳥見町2丁目130番地 日本メナード化粧品株式会社中央研究所 内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Akio Monobe 2-130, Torimi-cho, Nishi-ku, Nagoya, Aichi Prefecture, Central Research Institute, Japan Menard Cosmetics Co., Ltd. (72) Iwa Fukunaga 2 Torimi-cho, Nishi-ku, Nagoya, Aichi Prefecture 130-chome, Central Research Institute, Japan Menard Cosmetics Co., Ltd.
Claims (1)
することを特徴とする化粧料。1. A cosmetic comprising a water-soluble extract of coconut palm fruit.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3029471A JP2896815B2 (en) | 1991-01-29 | 1991-01-29 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3029471A JP2896815B2 (en) | 1991-01-29 | 1991-01-29 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0672838A true JPH0672838A (en) | 1994-03-15 |
| JP2896815B2 JP2896815B2 (en) | 1999-05-31 |
Family
ID=12277016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3029471A Expired - Lifetime JP2896815B2 (en) | 1991-01-29 | 1991-01-29 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2896815B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001031580A (en) * | 1999-05-19 | 2001-02-06 | Kose Corp | Preparation for external use for skin |
| EP1325738A3 (en) * | 2001-12-28 | 2004-05-06 | Avon Products, Inc. | Topical lightening compositions and methods of use |
| EP1465647A4 (en) * | 2001-12-28 | 2006-07-26 | Avon Prod Inc | Topical cosmetic composition having a natural plant active ingredient and method of using same |
| WO2008143685A1 (en) * | 2007-05-20 | 2008-11-27 | Sami Labs Limited | Method for recovering enriched indian date extract and properties and applications thereof |
| JP2011162518A (en) * | 2010-02-15 | 2011-08-25 | Noevir Co Ltd | Humectant and skin care preparation for external use |
| WO2015141645A1 (en) * | 2014-03-20 | 2015-09-24 | 高砂香料工業株式会社 | Method for producing palm fruit extract, palm fruit extract, flavor improving agent comprising palm fruit extract, and foods and drinks containing flavor improving agent |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3105312B2 (en) | 1991-10-09 | 2000-10-30 | 有限会社野々川商事 | Cosmetics |
| BR112015021033B1 (en) | 2013-03-08 | 2020-08-04 | Unilever N.V | COSMETIC COMPOSITION, NON-THERAPEUTIC METHODS TO REDUCE OR TREAT SKIN AGING SIGNS AND TO PREVENT, LIGHTEN OR REDUCE THE APPEARANCE OF VISIBLE SKIN DISCONTINUITIES AND USES OF A COMPOSITION |
| CN109431828B (en) | 2013-03-12 | 2021-11-12 | 雅芳产品公司 | Topical lightening compositions and methods of use thereof |
-
1991
- 1991-01-29 JP JP3029471A patent/JP2896815B2/en not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001031580A (en) * | 1999-05-19 | 2001-02-06 | Kose Corp | Preparation for external use for skin |
| EP1325738A3 (en) * | 2001-12-28 | 2004-05-06 | Avon Products, Inc. | Topical lightening compositions and methods of use |
| EP1465647A4 (en) * | 2001-12-28 | 2006-07-26 | Avon Prod Inc | Topical cosmetic composition having a natural plant active ingredient and method of using same |
| US7544351B2 (en) * | 2001-12-28 | 2009-06-09 | Avon Products, Inc | Topical lightening compositions and methods of use |
| WO2008143685A1 (en) * | 2007-05-20 | 2008-11-27 | Sami Labs Limited | Method for recovering enriched indian date extract and properties and applications thereof |
| JP2011162518A (en) * | 2010-02-15 | 2011-08-25 | Noevir Co Ltd | Humectant and skin care preparation for external use |
| WO2015141645A1 (en) * | 2014-03-20 | 2015-09-24 | 高砂香料工業株式会社 | Method for producing palm fruit extract, palm fruit extract, flavor improving agent comprising palm fruit extract, and foods and drinks containing flavor improving agent |
| JP2015181354A (en) * | 2014-03-20 | 2015-10-22 | 高砂香料工業株式会社 | Method for manufacturing extract of coconut |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2896815B2 (en) | 1999-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2890212B2 (en) | Cosmetics | |
| JPWO1996000561A1 (en) | hair growth agent | |
| JPH08119825A (en) | Hydroxytyrosol, application for skin external medicine or bathing agent | |
| JP3053368B2 (en) | Cosmetic and method for producing the same | |
| JP3084104B2 (en) | Cosmetics | |
| JPH0892057A (en) | Cosmetics containing coffee tree seed extract | |
| JP3170070B2 (en) | External preparation for skin | |
| JP2896815B2 (en) | Cosmetics | |
| KR101078888B1 (en) | A cosmetic composition comprising tissue cultured Echinaceae adventitious roots and an preparing method thereof | |
| JP2002370922A (en) | Cosmetics containing plum extract | |
| JP2002179529A (en) | Composition for bleaching | |
| JP3010560B2 (en) | Cosmetics | |
| JPH07277920A (en) | Cosmetic containing steam-distilled water and/or extract of lemongrass | |
| JP2003081746A (en) | Extension inhibitor of dendrite of melanocyte and cosmetic containing the same | |
| JPH0640933A (en) | Antiinflammatory agent | |
| JPH04346912A (en) | Cosmetic | |
| JP3027409B2 (en) | Cosmetics | |
| JPH01139517A (en) | Cosmetic | |
| JP2896816B2 (en) | Cosmetics | |
| JP2896814B2 (en) | Cosmetics | |
| JP2001131079A (en) | Skin preparation for external use | |
| JP5047511B2 (en) | Granulocyte-macrophage colony-stimulating factor (GM-CSF) production inhibitor I | |
| JP2002068956A (en) | Skin cosmetics | |
| JPH05320034A (en) | Cosmetic | |
| JPH04279511A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080312 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110312 Year of fee payment: 12 |
|
| EXPY | Cancellation because of completion of term |